Elevated IL-1β has been associated with pancreatitis, a recognized risk factor for PDA (120) and high intratumoral and serum IL-1β has been associated with poorer overall survival and increased chemoresistance in PDA patients (121–123). The gene discussed is IL1B; the disease is Patent ductus arteriosus.